Tenet Healthcare (NYSE:THC) Upgraded by Wall Street Zen to Strong-Buy Rating

Wall Street Zen upgraded shares of Tenet Healthcare (NYSE:THC) from a buy rating to a strong-buy rating in a research report released on Sunday.

A number of other research analysts have also issued reports on the company. Guggenheim reduced their price target on Tenet Healthcare from $283.00 to $252.00 and set a “buy” rating for the company in a research report on Friday. TD Cowen restated a “buy” rating on shares of Tenet Healthcare in a report on Thursday, February 12th. Royal Bank Of Canada cut their price objective on Tenet Healthcare from $277.00 to $236.00 and set an “outperform” rating for the company in a report on Friday. Cantor Fitzgerald restated an “overweight” rating on shares of Tenet Healthcare in a report on Wednesday, March 4th. Finally, Wells Fargo & Company reduced their target price on Tenet Healthcare from $265.00 to $213.00 and set an “overweight” rating for the company in a report on Friday. One analyst has rated the stock with a Strong Buy rating, eighteen have issued a Buy rating and three have issued a Hold rating to the company. According to MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and a consensus target price of $241.94.

Tenet Healthcare Price Performance

Shares of THC opened at $183.23 on Friday. The company has a market cap of $16.05 billion, a P/E ratio of 9.53, a PEG ratio of 1.37 and a beta of 1.30. The stock has a fifty day moving average price of $207.31 and a 200 day moving average price of $204.33. The company has a debt-to-equity ratio of 1.96, a current ratio of 1.36 and a quick ratio of 1.30. Tenet Healthcare has a 12 month low of $145.27 and a 12 month high of $247.21.

Tenet Healthcare (NYSE:THC) last issued its quarterly earnings data on Thursday, April 30th. The company reported $4.82 EPS for the quarter, topping analysts’ consensus estimates of $4.21 by $0.61. The firm had revenue of $5.37 billion during the quarter, compared to the consensus estimate of $5.39 billion. Tenet Healthcare had a return on equity of 25.55% and a net margin of 7.94%.The firm’s revenue was up 2.6% on a year-over-year basis. During the same period in the prior year, the business earned $4.36 EPS. Tenet Healthcare has set its FY 2026 guidance at 16.380-18.68 EPS. On average, research analysts forecast that Tenet Healthcare will post 17.42 earnings per share for the current year.

Insider Activity at Tenet Healthcare

In other news, EVP Paola M. Arbour sold 6,500 shares of the stock in a transaction that occurred on Wednesday, March 11th. The stock was sold at an average price of $238.43, for a total value of $1,549,795.00. Following the completion of the transaction, the executive vice president directly owned 29,291 shares of the company’s stock, valued at approximately $6,983,853.13. This represents a 18.16% decrease in their position. The sale was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, insider R. Scott Ramsey sold 8,017 shares of the stock in a transaction that occurred on Monday, March 2nd. The stock was sold at an average price of $232.70, for a total value of $1,865,555.90. The disclosure for this sale is available in the SEC filing. Insiders sold a total of 46,517 shares of company stock worth $10,943,111 in the last 90 days. 0.81% of the stock is owned by company insiders.

Institutional Investors Weigh In On Tenet Healthcare

A number of institutional investors and hedge funds have recently added to or reduced their stakes in the stock. Triumph Capital Management acquired a new position in Tenet Healthcare in the third quarter valued at about $25,000. Activest Wealth Management acquired a new position in Tenet Healthcare in the fourth quarter valued at about $26,000. Elyxium Wealth LLC acquired a new position in Tenet Healthcare in the fourth quarter valued at about $29,000. William B. Walkup & Associates Inc. acquired a new position in Tenet Healthcare in the third quarter valued at about $32,000. Finally, Westside Investment Management Inc. grew its stake in Tenet Healthcare by 100.0% in the third quarter. Westside Investment Management Inc. now owns 192 shares of the company’s stock valued at $39,000 after acquiring an additional 96 shares during the period. Institutional investors own 95.44% of the company’s stock.

Key Stories Impacting Tenet Healthcare

Here are the key news stories impacting Tenet Healthcare this week:

• Positive Sentiment: Q1 earnings beat and solid profitability — Tenet reported $4.82 EPS, well ahead of consensus, and showed healthy margins and ROE; investors favor the earnings beat even though revenue was roughly in-line. Tenet Healthcare (THC) Q1 Earnings Top Estimates
• Positive Sentiment: Strategic growth via ASC acquisitions — Tenet deployed ~$125M to acquire seven ambulatory surgery centers in Q1 and signals more M&A in the outpatient space, supporting revenue diversification and higher-margin outpatient growth. Tenet deployed $125M on 7 ASC acquisitions in Q1, eyes more deals
• Positive Sentiment: Operational momentum in procedures and robotics — The company is seeing double?digit joint replacement growth and expanding robotic programs across ASCs/hospitals, evidence that its outpatient acuity push is producing revenue mix benefits longer term. Double-digit joint replacement growth
• Neutral Sentiment: Analysts trimmed price targets but kept Buy/Outperform/Overweight ratings — Multiple firms cut PTs (RBC to $236, Guggenheim to $252, Wells Fargo to $213, KeyCorp to $225) while retaining positive ratings, which gives the stock continued sell?side endorsement but signals more conservative valuation assumptions. Analyst price target coverage (Benzinga summaries) TickerReport coverage
• Neutral Sentiment: Market commentary and investor takeaways — Several pieces are advising investors to weigh analyst views and the company’s outpatient strategy at current levels; these articles are shaping investor positioning rather than delivering new fundamental news. Seeking Alpha: Investor commentary
• Negative Sentiment: Revenue softness and admissions?mix headwinds — Management flagged admissions mix and external disruptions as reasons revenue missed expectations modestly; that weak revenue signal tempers the EPS beat and is the main near-term risk. Tenet Healthcare Blames Admissions Mix For Soft Q1 Sales

About Tenet Healthcare

Tenet Healthcare Corporation (NYSE: THC) is a diversified American healthcare services company that owns and operates acute care hospitals and a broad range of outpatient facilities. Its portfolio includes general acute-care hospitals, specialty hospitals, ambulatory surgery centers, urgent care and diagnostic imaging centers, and other ancillary service locations. Tenet’s operations are oriented around delivering inpatient and outpatient clinical care across multiple medical specialties, with an emphasis on surgical services, emergency care, and advanced diagnostics.

In addition to facility-based care, Tenet provides integrated services designed to support clinical operations and improve patient access and care coordination.